Combined use of anti-ErbB monoclonal antibodies and erlotinib enhances antibody-dependent cellular cytotoxicity of wild-type erlotinib-sensitive NSCLC cell lines

by Cavazzoni Andrea, Alfieri Roberta R, Cretella Daniele, Saccani Francesca, Ampollini Luca, Galetti Maricla, Quaini Federico, Graiani Gallia, Madeddu Denise, Mozzoni Paola, Galvani Elena, La Monica Silvia, Bonelli Mara, Fumarola Claudia, Mutti Antonio, Carbognani Paolo, Tiseo Marcello, Barocelli Elisabetta, Petronini Pier Giorgio, Ardizzoni Andrea
Published 2012-12-01